| Kathlene Herbermann, AA | |
|
1133 Eagles Landing Pkwy, Stockbridge, GA 30281-5085 | |
| (678) 604-1053 | |
| (678) 604-5548 |
| Full Name | Kathlene Herbermann |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 14 Years |
| Location | 1133 Eagles Landing Pkwy, Stockbridge, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619297918 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent's Clay County | Middleburg, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Florida Anesthesia Consultants Inc | 7416869565 | 114 |
News Archive
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
An analysis of North Carolina birth and educational records suggests that induction (stimulating uterine contractions prior to the onset of spontaneous labor) and augmentation (increasing the strength, duration, or frequency of uterine contractions with spontaneous onset of labor) during childbirth appears to be associated with increased odds of autism diagnosis in childhood, according to a study by Simon G. Gregory, Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues.
A major new Commission on women and health has found that women are contributing around $3 trillion to global health care, but nearly half of this (2.35% of global GDP) is unpaid and unrecognised.
As the first wave of "want to be forever young" baby boomers turns 60, Saint Louis University is creating a new center for research, education and clinical care to help them reach their goal.
› Verified 3 days ago
| Entity Name | North Florida Anesthesia Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346236866 PECOS PAC ID: 7416869565 Enrollment ID: O20031105000664 |
News Archive
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
An analysis of North Carolina birth and educational records suggests that induction (stimulating uterine contractions prior to the onset of spontaneous labor) and augmentation (increasing the strength, duration, or frequency of uterine contractions with spontaneous onset of labor) during childbirth appears to be associated with increased odds of autism diagnosis in childhood, according to a study by Simon G. Gregory, Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues.
A major new Commission on women and health has found that women are contributing around $3 trillion to global health care, but nearly half of this (2.35% of global GDP) is unpaid and unrecognised.
As the first wave of "want to be forever young" baby boomers turns 60, Saint Louis University is creating a new center for research, education and clinical care to help them reach their goal.
› Verified 3 days ago
| Entity Name | University Of Florida Jacksonville Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144276452 PECOS PAC ID: 9133025869 Enrollment ID: O20040128000786 |
News Archive
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
An analysis of North Carolina birth and educational records suggests that induction (stimulating uterine contractions prior to the onset of spontaneous labor) and augmentation (increasing the strength, duration, or frequency of uterine contractions with spontaneous onset of labor) during childbirth appears to be associated with increased odds of autism diagnosis in childhood, according to a study by Simon G. Gregory, Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues.
A major new Commission on women and health has found that women are contributing around $3 trillion to global health care, but nearly half of this (2.35% of global GDP) is unpaid and unrecognised.
As the first wave of "want to be forever young" baby boomers turns 60, Saint Louis University is creating a new center for research, education and clinical care to help them reach their goal.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathlene Herbermann, AA 909 Eagles Landing Pkwy, Suite 140-214, Stockbridge, GA 30281-7247 Ph: (678) 604-1053 | Kathlene Herbermann, AA 1133 Eagles Landing Pkwy, Stockbridge, GA 30281-5085 Ph: (678) 604-1053 |
News Archive
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
An analysis of North Carolina birth and educational records suggests that induction (stimulating uterine contractions prior to the onset of spontaneous labor) and augmentation (increasing the strength, duration, or frequency of uterine contractions with spontaneous onset of labor) during childbirth appears to be associated with increased odds of autism diagnosis in childhood, according to a study by Simon G. Gregory, Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues.
A major new Commission on women and health has found that women are contributing around $3 trillion to global health care, but nearly half of this (2.35% of global GDP) is unpaid and unrecognised.
As the first wave of "want to be forever young" baby boomers turns 60, Saint Louis University is creating a new center for research, education and clinical care to help them reach their goal.
› Verified 3 days ago
Sharla Phipps-mcgregor, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1053 | |
Morgan Kristine Dawson, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1740 Hudson Bridge Rd, Suite 1218, Stockbridge, GA 30281 Phone: 678-604-1053 | |
Cori Leanne Bruce, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-2053 | |
Briana Nicole Tate-york, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1000 | |
Aleksandr Fedovskiy, PAAA Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1053 | |
Alexander Lee, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1053 | |
Azim Dayani, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1053 |